The global electrosurgical/electrosurgery devices market size was USD 5.33 Billion in 2021 and is expected to register a revenue CAGR of 6.6% during the forecast period. Rising demand for minimally invasive surgeries, increasing adoption of technologically advanced products, and growing awareness regarding most recent surgical techniques in developing regions are major factors driving market revenue growth.
Electrosurgical procedures are used in various medical disciplines including urology, pneumology, gynecology, gastroenterology, abdominal surgery, general surgery, and others. In both open and minimally invasive surgery, electrosurgery is the most often utilized type of surgical method. Advanced electrosurgical equipment has revolutionized laparoscopic surgery with the adoption of increasingly intricate treatments. In surgeries, electrosurgery is a procedure that is frequently used to reduce bleeding and quickly dissect soft tissue. Heat is produced by these soft tissues’ electrical resistance to an electromagnetic current. Electrosurgical endpoints vary depending on waveform, power, and surgical approach. On the target tissue, this has a number of impact that provides various benefits, while surgery, for instance, reduces application-related bleeding to a minimum, enables more accurate cutting and coagulation settings, and provides a comparatively quick approach for tissue ablation or excision, which are also expected to drive revenue growth of the market.
Request a Sample@ https://www.qyresearchmedical.com/sample/119160
Government entities’ primary priority is on enhancing healthcare infrastructures, especially critical care infrastructure, in their various healthcare systems, which is increasing development of healthcare infrastructure globally and driving market growth. Many developed countries’ federal organizations are taking steps to enhance their current healthcare systems by boosting healthcare investments in improving infrastructure and lowering cost of healthcare services. Furthermore, rising activities by multiple key companies is expected to drive market growth. For instance, on 11 November 2022, Global Dental Services (GDS), Asia’s biggest dental network, received a USD 67 million investment from Investcorp, a company based in Bahrain and owing to this investment they are improving their healthcare infrastructure with new and innovative technology, which is causing a high demand for electrosurgical/electrosurgery devices.
Electrosurgical devices provide multiple advantages over diode lasers, which is expected to drive market growth. Electrosurgery is more cost-efficient than diode laser and electrosurgery electrode (wire) could be bent to achieve the desired clinical shape, making it simple to smooth soft tissue in uneven palatal or pontic regions that need to be contoured. When compared to a diode laser, electrosurgery cuts quite swiftly and the wound is nearly painless after being cut. Furthermore, electrosurgery electrode tips can be altered to resemble pencils, enabling incredibly small and accurate incisions, which is driving market growth.
Driver: Innovation and technological advancement in electrosurgical instruments
Technological advancements in safety and performance of Electrosurgical Units (ESUs) have made ESU the most common piece of electrical equipment, which is driving market growth. Electrosurgery is frequently utilized in procedures related to reproduction and technical developments to increase effectiveness and lower risk of problems. In bipolar electrosurgical systems, both electrodes are encased in the same surgical tool and the only area of patient’s body involved in electrical circuit is target tissue between two electrodes. This reduces rate of complications related to dispersive electrode site burn and increases accuracy. Furthermore, bipolar systems have decreased iatrogenic problems and provided dependable and safe results in coagulation and desiccation operations, due to unintended heat distribution, which is also driving market growth.
Restraint: Risks associated with electrosurgical procedures
Although electrosurgical devices operate efficiently for many years without repair and are inexpensive, it has various disadvantages such as risks associated with electrosurgical procedures. For instance, drawbacks using electrosurgery produces a stronger smell of burnt flesh than using a diode laser, while burning taste of flesh left in the mouth after electrosurgery lasts for a long time. In addition, electrosurgery requires anesthesia for patients, hence overcutting of tissue can occur due to quick cutting capacity of electrosurgery and limited tactile feeling when cutting. Furthermore, electrosurgery can’t be utilized close to implants since it generates a lot of heat during cutting, which is expected to restrain market growth.
Based on surgery, the global electrosurgical/electrosurgery devices market is segmented into obstetric/gynecological surgery, general surgery, orthopedic surgery, cardiovascular surgery, cosmetic surgery, urological surgery, and neurosurgery. The cardiovascular surgery segment accounted for largest revenue share in 2021. Electrosurgical surgery for heart surgery is performed through extremely small wounds in chest. The procedure for performing cardiac surgery is far less invasive than open heart surgery because of the use of small equipment and controlled tools. Furthermore, numerous heart-related treatments, such as valve surgery, coronary artery bypass, cardiac tissue ablation, heart defect repair, and tumor excision, have been performed using electrosurgical devices, which is driving revenue growth of this segment.
The cosmetic surgery segment is expected to register a steady revenue growth rate during the forecast period. Benefit of electrosurgery is that it uses less energy than direct touch electrodesiccation, while having enough strength to halt bleeding. In addition, it can leave fewer scars than electrodesiccation, which is highly beneficial for cosmetic surgery, thus, rising demand for electrosurgical devices and driving revenue growth of this segment.
Based on end-use, the global electrosurgical/electrosurgery devices market is segmented into hospitals, ambulatory surgical centers, and research laboratories & academic institutes. The hospitals segment accounted for largest revenue share in 2021. Hospitals are embracing electrosurgical devices at an increasing rate owing to their multiple advantages such as minimizing bleeding at the application and high accuracy. Furthermore, surgeons can modify unit output setting for a range of operations by changing the technique, mode, and power settings (wattage), which are highly beneficial in the operation theater, thus driving revenue growth of this segment.
The ambulatory surgical centers segment is expected to register a moderate revenue growth rate during the forecast period owing to safety, comfort, and convenience. Ambulatory service centers are an ideal option for older adults as it provides personalized care and prevents frequent trips to hospitals. Outpatient surgery centers can be 45%-60% less expensive than hospitals, which benefits patients, insurers, and taxpayers equally and outpatient surgery centers have better control over scheduling of surgeries. As a result, practically very few procedures may be delayed or rescheduled compared to hospital’s unanticipated circumstances such as emergency room difficulties. It also limits patients from contracting hospital-acquired infections, which is driving revenue growth of the market.
Based on regional analysis, the North America market accounted for largest revenue share in 2021. Rising Research & Development (R&D) by various manufacturers to develop advanced and innovative electrosurgical devices and increasing approval of these devices are expected to drive market growth in this region. For instance, on 15 October 2019, Apyx Plasma/RF Handpiece, a new product in the Renuvion family, has been approved by U.S. Food and Drug Administration (FDA), according to Apyx Medical, a U.S.-based medical device maker. Apyx Plasma/RF Handpiece is particularly made for subdermal coagulation and has significant upgrades to fulfill demands cosmetic surgeries in the market.
The Asia Pacific market is expected to register a steady revenue growth rate during the forecast period. Developing countries in this region, such as India, China, and Japan, are increasingly taking initiative to develop new products in this region, which is expected to drive market growth. For example, on 29 September 2022, THUNDERBEAT Open Fine Jaw Type X single-use hybrid ultrasonic and bipolar electrosurgical device for open surgery has been released by Olympus. It is now available in the Japan market and in October it will be launched in South Korea, Europe, and the U.S. markets.
The Europe market is expected to register a moderate revenue growth rate during the forecast period. Increasing activities by major manufacturers in this region to develop advanced and innovative solutions is expected to drive market growth. For instance, on 3 April 2019, Zeus, a portable multi-frequency plasma and electrosurgical device, has been introduced by 4T Medical in the UK. The Class IIb Medical Device is capable of carrying out both surgical and non-surgical treatments in specialties including gynecology, dermatology, vascular surgery, and cosmetic medicine.
Competitive landscape of the global electrosurgical/electrosurgery devices market is consolidated with a few key players operating on global and regional levels. Key players are engaged in product development and strategic alliances to expand their respective product portfolios and gain a robust footing in the global market. Major players in the market include Olympus Corporation, Medtronic, Parkell, Inc., Smith+Nephew, Boston Scientific Corporation, B. Braun SE, Kirwan Surgical Products, LLC., Apyx Medical, ATMOS MedizinTechnik GmbH & Co. KG, and Zimmer Biome.
Initiatives taken by market players are driving growth of the market, for instance:
In September 21 2022, U.S. Medical Innovations, LLC. (USMI), a subsidiary of U.S. Patent Innovations, LLC. stated it had obtained a USD 10.2 million private placement agreement from a number of sources, including previous partners and new investors. These funds will be used by USMI to increase production of its recently released Canady Plasma XL-1000 SMART Electrosurgical Generator (XL-1000) and support creation and commercialization of its Canady HeliosCold Plasma Generator (CHCP) and robotic delivery system for targeted treatment of cancer.
Segments Covered in the Report
This report offers historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of the market trends in each of the sub-segments from 2022 to 2030. For this study have segmented the electrosurgical/electrosurgery devices market based on product, surgery, end-use, and region:
Electrosurgical/Electrosurgery Devices Market Report Scope
Segments covered By Product Outlook, Surgery Outlook, End-Use Outlook, Regional Outlook
By Product Outlook
Smoke Evacuation systems
By Surgery Outlook
By End-Use Outlook
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119160/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: